Diisopropylamine → HCID 13104634, Verbindung

HRID 64807

Reaktionsgleichung

Reaktionsgleichung von HRID 64807
C([Li])CCC.C(NC(C)C)(C)C.[C:13]([O:16][CH2:17][C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1)(=[O:15])[CH3:14].[Si:24]([N:31]1[C@H:34]([CH2:35][CH:36]=[O:37])[C@@H:33]([C@H:38]([O:40][Si:41]([C:44]([CH3:47])([CH3:46])[CH3:45])([CH3:43])[CH3:42])[CH3:39])[C:32]1=[O:48])([C:27]([CH3:30])([CH3:29])[CH3:28])([CH3:26])[CH3:25]>O1CCCC1>[Si:24]([N:31]1[C@H:34]([CH2:35][CH:36]([OH:37])[CH2:14][C:13]([O:16][CH2:17][C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)=[O:15])[C@@H:33]([C@H:38]([O:40][Si:41]([C:44]([CH3:47])([CH3:46])[CH3:45])([CH3:42])[CH3:43])[CH3:39])[C:32]1=[O:48])([C:27]([CH3:30])([CH3:28])[CH3:29])([CH3:26])[CH3:25]

Komponenten

6

Edukt 4

HCID 7912DiisopropylamineHCID 8785Benzyl acetateHCID 11003560HCID 11003560, VerbindungHCID 178418339Butyllithium

Produkt 1

HCID 13104634HCID 13104634, Verbindung

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028TetrahydrofuranLösungsmittel2×

Reaktionsbedingungen

Temperatur
-78 °C

Versuchsvorschrift

n-Butyllithium (1.81 mmol) is added by syringe to a solution of diisopropylamine (1.81 mmol) in 9 ml of freshly distilled tetrahydrofuran at -78° C. The resulting solution is stirred for 15 min at -78° C. Benzyl acetate (1.81 mmol) is then added dropwise by syringe and the resulting solution is stirred at -78° C. for 20 min. A solution of (3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-4-(2-oxoethyl)azetidin-2-one (1.64 mmol) in 3 ml of anhydrous tetrahydrofuran is added slowly by syringe. The reaction mixture is stirred at -78° C. an additional 15 min and then quenched by addition of saturated aqueous ammonium chloride solution. Ethyl acetate (50 ml) is added and the organic phase is separated, washed with water (2×10 ml) and brine and dried over magnesium sulfate. Removal of solvents in vacuo gives a white solid which is chromatographed on a short silica gel column (40% ether in petroleum ether) to yield (3S,4R)-1-(t-butyldimethylsilyl)-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-4-(3-benzyloxycarbonyl-2-hydroxypropyl)azetidin-2-one. n.m.r. (CDCl3) δ7.32(s,5), δ5,1(s,2), δ4.0(m,3), δ2,4-3,8(m,4), δ2.0(m,2), δ1.25(overlapping d, 3), δ0.95(s,9), δ0.9(s,9), δ0.3(s,6), δ0.18(s,6).

Aufarbeitung

  1. stirringthe resulting solution is stirred at -78° C. for 20 min
  2. stirringThe reaction mixture is stirred at -78° C. an additional 15 min
  3. customquenched by addition of saturated aqueous ammonium chloride solution
  4. additionEthyl acetate (50 ml) is added
  5. customthe organic phase is separated
  6. washwashed with water (2×10 ml) and brine
  7. dry with materialdried over magnesium sulfate
  8. customRemoval of solvents in vacuo
  9. customgives a white solid which
  10. customis chromatographed on a short silica gel column (40% ether in petroleum ether)

Quellen und Nachweise

ORD-Eintrag
ord-befecda3a2834194a0fcbce2f30a8afe
Quelldatensatz
uspto-grants-1986_09
Patentnummer
US04610820

Verknüpfte Notizen

Wird geladen…